Results 1 to 10 of about 29,628 (150)

Plasma soluble triggering receptor expressed on myeloid cells 2 levels and clinical outcomes in acute decompensated heart failure: A retrospective cohort study [PDF]

Journal of International Medical Research
Objective Emerging evidence suggests a potential role for soluble triggering receptor expressed on myeloid cells 2 (sTREM2) in cardiovascular pathophysiology.
Jie Li, Mengyu Wang, Jing Ma, Shuwen Zheng, Yinong Chen, Furong Yang, Yingying Xie, Wenjing Wu, Mengwen Yan, Peiran Yang, Zhenguo Zhai, Yihong Sun   +11 more
doaj   +2 more sources

Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background It remains unclear whether beta‐blocker use at hospital admission is associated with better in‐hospital outcomes in patients with acute decompensated heart failure.
Yodo Tamaki, Hidenori Yaku, Takeshi Morimoto, Yasutaka Inuzuka, Neiko Ozasa, Erika Yamamoto, Yusuke Yoshikawa, Makoto Miyake, Hirokazu Kondo, Toshihiro Tamura, Takeshi Kitai, Moritake Iguchi, Kazuya Nagao, Ryusuke Nishikawa, Yuichi Kawase, Takashi Morinaga, Mitsunori Kawato, Mamoru Toyofuku, Yukihito Sato, Koichiro Kuwahara, Yoshihisa Nakagawa, Takao Kato, Takeshi Kimura   +22 more
doaj   +3 more sources

Acute Kidney Disease After Acute Decompensated Heart Failure

Kidney International Reports, 2022
Introduction: Acute kidney disease (AKD) represents a continuum of kidney injury for 7 to 90 days after acute kidney injury (AKI). The incidence and prognosis of AKD after acute decompensated heart failure (ADHF) are currently unclear.
Jia-Jin Chen, Tao-Han Lee, George Kuo, Chieh-Li Yen, Shao-Wei Chen, Pao-Hsien Chu, Pei-Chun Fan, Victor Chien-Chia Wu, Chih-Hsiang Chang   +8 more
doaj   +3 more sources

Development and Validation of a Risk Score for Prediction of Acute Kidney Injury in Patients With Acute Decompensated Heart Failure: A Prospective Cohort Study in China

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundAlthough several risk factors for acute kidney injury (AKI) have been identified, early detection of AKI in acute decompensated heart failure patients remains a challenge. The aim of this study was to develop and validate a risk score for early
Li Zhi Zhou, Xiao Bing Yang, Ying Guan, Xing Xu, Ming T. Tan, Fan Fan Hou, Ping Yan Chen   +6 more
doaj   +3 more sources

Acute Decompensated Heart Failure [PDF]

Critical Care Clinics, 2007
This article defines acute decompensated heart failure. Additionally, it lists common precipitating factors and the clinical presentation. Proper diagnostic technique is highlighted, as are possible treatments.
James F, Neuenschwander, Ragavendra R, Baliga   +1 more
  +8 more sources

Acute Decompensated Heart Failure

Cardiology Clinics, 2012
Acute decompensated heart failure (ADHF) is the most common cause of cardiovascular hospital admission; 1 in 4 patients with heart failure is readmitted within 30 days of being discharged, and ADHF consumes 1% to 2% of the total health care resources.
Jennifer R, Brown, Stephen S, Gottlieb
  +9 more sources

Management of Acute Decompensated Heart Failure [PDF]

Critical Care Nursing Quarterly, 2007
Heart failure, a debilitating complex clinical syndrome, affects nearly 5 million people in the United States and presents a heavy socioeconomic burden. Neurohormonal abnormalities contribute to the pathophysiology of heart failure. Acute decompensated heart failure (ADHF) has emerged as a major health problem associated with poor prognosis, increased ...
Larry A, Allen, Christopher M, O'Connor
  +7 more sources

SGLT2 inhibitors in acute decompensated heart failure, what do we know?

Терапевтический архив, 2022
The current worldwide prevalence of heart failure is growing, while its combination with cardiovascular and other conditions determines a poor prognosis in these patients.
Anastasiya E. Lapteva, Svetlana N. Nasonova, Igor V. Zhirov, Sergey N. Tereshchenko   +3 more
doaj   +1 more source

Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.

PLoS ONE, 2021
BackgroundAdmission systolic blood pressure has emerged as a predictor of postdischarge outcomes of patients with acute decompensated heart failure; however, its validity in varied clinical conditions of this patient subset is unclear.
Yuichi Kawase, Takao Kato, Takeshi Morimoto, Reo Hata, Ryosuke Murai, Takeshi Tada, Harumi Katoh, Kazushige Kadota, Erika Yamamoto, Hidenori Yaku, Yasutaka Inuzuka, Yodo Tamaki, Neiko Ozasa, Yusuke Yoshikawa, Moritake Iguchi, Kazuya Nagao, Yukihito Sato, Koichiro Kuwahara, Takeshi Kimura   +18 more
doaj   +1 more source

Severity of Functional Mitral Regurgitation on Admission for Acute Decompensated Heart Failure Predicts Long‐Term Risk of Rehospitalization and Death

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background Functional mitral regurgitation (FMR) has emerged as a therapeutic target in patients with chronic heart failure and left ventricular systolic dysfunction. The significance of FMR in acute decompensated heart failure remains obscure.
Rachna Kataria, Francesco Castagna, Shivank Madan, Paul Kim, Omar Saeed, Yaw A. Adjepong, Angelos A. Melainis, Cynthia Taub, Mario J. Garcia, Azeem Latib, Ulrich P. Jorde   +10 more
doaj   +1 more source